EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Brain metastasis in de novo stage IV breast cancer

Yaning He, Yingbo Shao, Qi Chen, Chaojun Liu, Fangyuan Zhu, Hui Liu

The Breast · 2023

DOI: 10.1016/j.breast.2023.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Breast, 2023. Verfasst von Yaning He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Oncology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China; Department of Breast Onc…. Hauptthemen laut MEDLINE: Breast Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Information of brain metastasis (BM) in de novo stage IV breast cancer is lacking, which is an unavoidable problem and dilemma in practice. Understanding the current situation is helpful for the clinical cognition and decision-making. METHODS: We retrospectively analyzed the clinical and survival information of de novo stage IV breast cancer with BM between 2015 and 2019 from the Surveillance, Epidemiology, and End Results (SEER) database. Multivariable logistic and Cox regression analyses were performed to identify predictors of BM and factors associated with all-cause mortality in de novo stage IV breast cancer, respectively. Overall survival (OS) was calculated using Kaplan-Meier and log-rank tests. RESULTS: Our cohort consisted of 1366 patients with BM in de novo stage IV breast cancer, with an incidence of 8.38% in patients with metastatic disease to any distant site. Incidence was highest among patients with metastatic disease with HR-HER2+ (12.95%) and HR-HER2- (13.40%) subtypes. The higher the number of extracranial metastases, the higher the BM incidence. The median OS was 12.0 (95%CI: 10.426-13.574) months in BM group; it was longest in HR + HER2+ (19.0[95%CI: 11.793-26.207] months), and shortest in HR-HER2- (7.0 [95%CI:5.354-8.646] months). Marital status, subtype, and abundance of metastatic sites influenced morbidity and OS of BM in de novo stage IV breast cancer. CONCLUSIONS: Population-based estimates of the incidence and prognosis for patients with BM in de novo stage IV breast cancer were closely associated with subtype and metastatic burden. These findings may be helpful in developing diagnostic strategies, especially for brain screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBrain NeoplasmsHumansFemaleRetrospective StudiesBrainCognitionPrognosisNeoplasm Metastasis

Stichwörter der Autor:innen

Brain metastasisPrognosisStage IVSubtypede novo breast cancer

Autor:innen und Institutionen

  • Department of Breast Oncology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China; Department of Breast Oncology, Henan Provincial People's Hospital, Henan University People's H…

Förderung

  • National Cancer Institute

Zitieren

APA

He, Y., Shao, Y., Chen, Q., Liu, C., Zhu, F., & Liu, H. (2023). Brain metastasis in de novo stage IV breast cancer. The Breast. https://doi.org/10.1016/j.breast.2023.07.005

Vancouver

He Y, Shao Y, Chen Q, Liu C, Zhu F, Liu H. Brain metastasis in de novo stage IV breast cancer. The Breast. 2023. doi:10.1016/j.breast.2023.07.005

BibTeX
@article{He2023,
  author = {He, Yaning and Shao, Yingbo and Chen, Qi and Liu, Chaojun and Zhu, Fangyuan and Liu, Hui},
  title = {Brain metastasis in de novo stage IV breast cancer},
  journal = {The Breast},
  year = {2023},
  doi = {10.1016/j.breast.2023.07.005}
}
Kostenlos starten →